Companies covered: Visa Inc. (NYSE:V), Mastercard Incorporated (NYSE:MA), Alibaba Group Holding Limited (NYSE:BABA), Amazon.com, Inc. (NASDAQ:AMZN), Paypal Holdings Inc (NASDAQ:PYPL), WEX Inc. (NYSE:WEX), Intuitive Surgical, Inc. (NASDAQ:ISRG), ABIOMED, Inc. (NASDAQ:ABMD), EXACT Sciences Corporation (NASDAQ:EXAS), NVIDIA Corporation (NASDAQ:NVDA), Microsoft Corporation (NASDAQ:MSFT), Twitter, Inc. (NYSE:TWTR), General Electric Company (NYSE:GE), Alphabet Inc (NASDAQ:GOOG), Facebook, Inc. (NASDAQ:FB), UnitedHealth Group Incorporated (NYSE:UNH), Merck & Company, Inc. (NYSE:MRK), Apple Inc. (NASDAQ:AAPL), Nokia Corporation (NYSE:NOK), Motorola Solutions, Inc. (NYSE:MSI), BlackBerry Ltd (NYSE:BB), Cerner Corporation (NASDAQ:CERN), BP p.l.c. (NYSE:BP), Biogen Inc. (NASDAQ:BIIB), Sally Beauty Holdings, Inc. (NYSE:SBH), Discovery Communications, Inc. (NASDAQ:DISCA), Walt Disney Company (The) (NYSE:DIS), Viacom Inc. (NASDAQ:VIA), CBS Corporation (NYSE:CBS), Netflix, Inc. (NASDAQ:NFLX), Wells Fargo & Company (NYSE:WFC), Kroger Company (The) (NYSE:KR), Walmart Inc. (NYSE:WMT), Costco Wholesale Corporation (NASDAQ:COST), SoftBank Group Corp (OTCMKTS:SFTBF), Carnival Corporation (NYSE:CCL), Comcast Corporation (NASDAQ:CMCSA), Fox Corp. (NASDAQ:FOXA), O'Reilly Automotive, Inc. (NASDAQ:ORLY), Toyota Motor Corp Ltd Ord (NYSE:TM), Royal Caribbean Cruises Ltd. (NYSE:RCL), Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH), Union Pacific Corporation (NYSE:UNP), Home Depot, Inc. (The) (NYSE:HD), American Axle & Manufacturing Holdings, Inc. (NYSE:AXL), General Motors Company (NYSE:GM), Quad Graphics, Inc (NYSE:QUAD), AMERISAFE, Inc. (NASDAQ:AMSF), Hercules Capital Inc (NYSE:HTGC), Myriad Genetics, Inc. (NASDAQ:MYGN), Catur Sentosa Adiprana Tbk PT (IDX:CSAP), Home Product Center Public Co. Ltd. (BKK:HMPRO), BBI Life Sciences Corp. (HKG:1035), Swedencare AB (STO:SECARE), PetIQ (NASDAQ:PETQ), De'Longhi SpA (BIT:DLG)
Companies covered: Gilead Sciences, Inc. (NASDAQ:GILD), Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), Cymabay Therapeutics Inc. (NASDAQ:CBAY), Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD), ChemoCentryx, Inc. (NASDAQ:CCXI), Five Prime Therapeutics, Inc. (NASDAQ:FPRX), Allergan, Inc. (NYSE:AGN), AbbVie Inc. (NYSE:ABBV), Genfit SA (OTCMKTS:GNFTF), Viking Therapeutics (NASDAQ:VKTX), Madrigal Pharmaceuticals (NASDAQ:MDGL), InflaRx NV (NASDAQ:IFRX), Ra Pharmaceuticals (NASDAQ:RARX), Jounce Therapeutics (NASDAQ:JNCE), Arcus Biosciences (NYSE:RCUS), ObsEva SA (NASDAQ:OBSV), Kindred Biosciences, Inc. (NASDAQ:KIN), NuCana plc (NASDAQ:NCNA), Verastem, Inc. (NASDAQ:VSTM), Cerecor Inc. (NASDAQ:CERC), Avenue Therapeutics, Inc. (NASDAQ:ATXI), CEL-SCI Corporation (NYSEAMERICAN:CVM), ImmuCell Corporation (NASDAQ:ICCC), Moleculin Biotech, Inc. (NASDAQ:MBRX), Innovest Global, Inc. (OTCMKTS:IVST), CytoDyn Inc. (OTCMKTS:CYDY), Immutep Limited (NASDAQ:IMMP), ERYTECH Pharma (NASDAQ:ERYP), Navidea Biopharmaceuticals, Inc. (NYSEAMERICAN:NAVB), Aquestive Therapeutics (NASDAQ:AQST), NanoViricides, Inc. (NYSEAMERICAN:NNVC), Entera Bio Ltd. (NASDAQ:ENTX)
Companies covered: GDS Holdings Ltd. (ADR) (NASDAQ:GDS), Alibaba Group Holding Limited (NYSE:BABA), Tencent Holdings Ltd. (OTCMKTS:TCEHY), Equinix, Inc. (NASDAQ:EQIX), Sify Technologies Limited (NASDAQ:SIFY), Amazon.com, Inc. (NASDAQ:AMZN), Berkshire Hathaway Inc. (NYSE:BRK/A), AT&T Inc. (NYSE:T), Alphabet Inc (NASDAQ:GOOG), CyrusOne Inc (NASDAQ:CONE), InterXion Holding N.V. (NYSE:INXN), Indivior PLC (LON:INDV), Dr. Reddy's Laboratories Ltd (NYSE:RDY), MiX Telematics Limited (NYSE:MIXT), Verizon Communications Inc. (NYSE:VZ), NexGen Energy Ltd. (NYSE:NXE), Cameco Corporation (NYSE:CCJ), American Water Works (NYSE:AWK), Atmos Energy Corporation (NYSE:ATO), NextEra Energy, Inc. (NYSE:NEE), Duke Energy Corporation (NYSE:DUK), DTE Energy Co. (NYSE:DTE), Netflix, Inc. (NASDAQ:NFLX), Facebook, Inc. (NASDAQ:FB), Eastman Kodak Company (NYSE:KODK), Xerox Corporation (NYSE:XRX), Goldman Sachs Group, Inc. (The) (NYSE:GS), KT Corporation (NYSE:KT), Gazprom PAO (OTCMKTS:OGZPY), Exxon Mobil Corporation (NYSE:XOM), Newcrest Mining Ltd. (ADR) (OTCMKTS:NCMGY)
Companies covered: Boeing Company (The) (NYSE:BA), Airbus SE (OTCMKTS:EADSY), United Technologies Corporation (NYSE:UTX), Honeywell International Inc. (NYSE:HON), Mercury Systems Inc (NASDAQ:MRCY), Aerojet Rocketdyne Holdings (NYSE:AJRD), Northrop Grumman Corporation (NYSE:NOC), Maxar Technologies Ltd. (NYSE:MAXR), Astronics Corporation (NASDAQ:ATRO), AAR Corp. (NYSE:AIR), Spirit Aerosystems Holdings, Inc. (NYSE:SPR), Woodward, Inc. (NASDAQ:WWD), Rockwell Collins, Inc. (NYSE:COL), KLX Inc. (NASDAQ:KLXI), United Parcel Service, Inc. (NYSE:UPS), Lockheed Martin Corporation (NYSE:LMT), Caterpillar, Inc. (NYSE:CAT), Emerson Electric Company (NYSE:EMR), Rockwell Automation, Inc. (NYSE:ROK), 3M Company (NYSE:MMM), American Superconductor Corporation (NASDAQ:AMSC), AMETEK (NYSE:AME), Sinovel Wind Group Company Limited (SHA:601558), Bombardier Inc (OTCMKTS:BDRBF), Embraer-Empresa Brasileira de Aeronautica (NYSE:ERJ), RBC Bearings Incorporated (NYSE:RBC), Kadant Inc (NYSE:KAI), Crane Company (NYSE:CR), Curtiss-Wright Corporation (NYSE:CW), inTest Corporation (NYSEAMERICAN:INTT), Heico Corporation (NYSE:HEI), Columbus McKinnon Corporation (NASDAQ:CMCO), Graham Corporation (NYSE:GHM), Cubic Corporation (NYSE:CUB), MTS Systems Corporation (NASDAQ:MTSC), Axon Enterprise, Inc. (NASDAQ:AXON), Williams Industrial Services Group Inc. (OTCMKTS:WLMS)
Companies covered: Oxford BioMedica plc (LON:OXB), miRagen Therapeutics, Inc. (NASDAQ:MGEN), IDEXX Laboratories, Inc. (NASDAQ:IDXX), The Medicines Company (NASDAQ:MDCO), Amgen Inc. (NASDAQ:AMGN), Biogen Inc. (NASDAQ:BIIB), Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Cooper Companies, Inc. (The) (NYSE:COO), Johnson & Johnson (NYSE:JNJ), Marathon Petroleum Corporation (NYSE:MPC), Pioneer Natural Resources Company (NYSE:PXD), Takeda Pharmaceutical Co. Ltd. (NYSE:TAK), Andeavor (NYSE:ANDV), Spark Therapeutics, Inc. (NASDAQ:ONCE), Audentes Therapeutics (NASDAQ:BOLD), Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), Zogenix, Inc. (NASDAQ:ZGNX), Novartis AG (NYSE:NVS), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Selecta Biosciences Inc (NASDAQ:SELB), ViewRay Inc. (NASDAQ:VRAY), Novocure Ltd. (NASDAQ:NVCR), Nightstar Therapeutics PLC (NASDAQ:NITE), Dentsply Sirona (NASDAQ:XRAY), Gilead Sciences, Inc. (NASDAQ:GILD), Celgene Corporation (NASDAQ:CELG), Qiagen N.V. (NASDAQ:QGEN), Cancer Genetics, Inc. (NASDAQ:CGIX), Acorda Therapeutics, Inc. (NASDAQ:ACOR), Sorrento Therapeutics, Inc. (NASDAQ:SRNE), Merck & Company, Inc. (NYSE:MRK), Bristol-Myers Squibb Company (NYSE:BMY), Bausch Health Companies (NYSE:BHC), Abeona Therapeutics (NASDAQ:ABEO), Acer Therapeutics (NASDAQ:ACER), HTG Molecular Diagnostics (NASDAQ:HTGM), Intec Pharma (NASDAQ:NTEC), Fate Therapeutics, Inc. (NASDAQ:FATE), bluebird bio, Inc. (NASDAQ:BLUE), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Applied Genetic Technologies Corporation (NASDAQ:AGTC), Unum Therapeutics (NASDAQ:UMRX), Blueprint Medicines Corp. (NASDAQ:BPMC), AVROBIO (NASDAQ:AVRO), Voyager Therapeutics (NASDAQ:VYGR), Fortress Biotech, Inc. (NASDAQ:FBIO), Interpace Diagnostics Group, Inc. (NASDAQ:IDXG), GenSight Biologics SA (OTCMKTS:GSGTF), Mustang Bio, Inc. (NASDAQ:MBIO)
